Access research focused on epilepsy in infants, children, and teens, including causes, treatments, developmental impacts, and family support strategies.
Researchers conducted a study to compare the effectiveness and safety of two medications, levetiracetam and sodium valproate, in treating children aged 1 to 16 years who were experiencing refractory generalized convulsive status epilepticus.
Researchers at Yangon Children’s Hospital studied the effectiveness of two medications, levetiracetam and phenobarbital, for treating prolonged seizures in children who did not respond to benzodiazepines.
Researchers conducted a study to analyze trends in pediatric epilepsy treatment research from 2005 to 2025.
Researchers studied a 12-year-old boy with a history of seizures and other health issues, including abnormal fat distribution and intellectual disability.
Researchers studied the use of a new form of medication called diazepam buccal film to help manage seizures in children with epilepsy.
Researchers conducted a study to explore how children with epilepsy feel about their ability to manage seizures and how this affects their quality of life and experiences of stigma.
Researchers studied the potential risk factors for epilepsy in children who experienced neonatal hypoglycemia, which is low blood sugar shortly after birth.
Researchers conducted a study to understand the causes and outcomes of hypoglycemic seizures in children.
Researchers conducted a study to compare two common medications used to treat epilepsy in children: levetiracetam and sodium valproate.